The cancer-derived Transforming Growth Factor-β (TGF-β) in PDAC patients plays an important role in converting normal fibroblasts into myofibroblastic CAFs (54), which produce αSMA, and fibroblast activation protein (FAP) (55). This evidence concerns the gene FAP and cancer.